Member Log In


News from our community

  • 27 Mar 2019 7:31 AM | Anonymous

    "By any measure, it is remarkable growth.  In the past five years, the University of Alabama at Birmingham School of Medicine has climbed 10 places on the National Institutes of Healthresearch funding rankings, from 31 in the nation to 21. Total NIH funding during that period rose from $133,264,288 in 2013 to $234,390,799 in 2018. The story of how Alabama’s flagship medical school came to be standing on the doorstep of the 20 top-funded schools in the nation is one of commitment, vision and hard work"

    Read Full Article Here


  • 25 Mar 2019 11:11 AM | Anonymous

    The NIH National Center for Advancing Translational Sciences (NCATS) is seeking applicants for its small business funding opportunities through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS offers annual funding for the development of innovative tools, technologies and intervention (drug, device, diagnostic) platforms that would support the creation of novel therapeutics. 

    NCATS has released a new SBIR contract solicitation to support small businesses interested in developing innovative health technologies. The standard deadlines to submit an application for open NCATS SBIR and STTR Omnibus Solicitation are April 5, 2019; September 5, 2019; and January 5, 2020.

    For more information about NCATS, its SBIR and STTR programs, and upcoming funding opportunities, visit the Small Business Opportunities page. If you have general questions about the NCATS SBIR and STTR program or want to discuss potential project ideas and related questions, email NCATS-SBIRSTTR@mail.nih.gov


  • 13 Dec 2018 1:30 PM | Anonymous member (Administrator)

    This year saw a renewed focus on the bioscience sector in Alabama – an industry that stretches to nearly every corner of the state. It was identified by local and state economic development groups as an area where the state is poised to grow.

    At the Economic Development Association of Alabama Winter Conference in February, Peggy Sammon, Chairman for BioAlabama, said the industry organization was ready to take the lead role in making that growth happen. To kick off their efforts, the group issued an impact study.

    Read Full Article Here

  • 20 Nov 2018 2:04 PM | Anonymous member (Administrator)

    The word “biotech” might evoke images of lab coats and petri dishes and, while that is certainly part of the story, BIO Alabama wants to make sure it isn’t the entire story.

    A new video with amped-up music and images that cut across a wide swath of the important industry aims to frame biotech differently in the state.

    Read Full Article Here


  • 1 Nov 2018 3:00 PM | Anonymous member (Administrator)

    The UAB Comprehensive Cancer Center has formed a partnership with the Lung Cancer Alliance to reach underserved people who are most at-risk for lung cancer. 

    A three-year, $1.6 million grant from the Bristol-Meyers Squibb Foundation will establish the Alabama Lung Cancer Awareness, Screening and Education program, which aims to address the racial and socioeconomic disparities in lung cancer, which are predominant in Alabama and the South.

    The ALCASE program will combine the Lung Cancer Alliance’s expertise in lung cancer screening and will expand the cancer center's Deep South Network Community Health Advisor model to decrease lung cancer diagnoses. The purpose of the overall program will be to increase participation and increase screenings by providing community-based support to local health care facilities

    Read Full Article Here

  • 22 Aug 2018 1:35 PM | Anonymous member (Administrator)

    CALL FOR NOMINATIONS

    Southeast BIO is pleased to announce the call for nominations for the 2018 SEBIO Awards. These annual awards honor healthcare and life sciences organizations in the Southeast US whose achievements are bringing the region into focus as a hub of medical and technological innovation.

    This year we will recognize companies from five categories, each representing a corporate or financial milestone. We will also recognize an individual with our customary Lifetime Achievement Award, reserved for passionate leaders who have made significant contributions to the life sciences industry in the Southeast.

    The catergories are: 

    • INITIAL FUNDING: Initial equity financing of less than $1 million
    • VENTURE FUNDING: Equity financing of greater than $1 million
    • STRATEGIC INVESTMENT: Strategic investment in award company by a peer
    • STRATEGIC ACQUISITION: Material acquisition of an award company or by an award company
    • INITIAL PUBLIC OFFERING: Initial securities offering to the public

    Recipients will be invited to accept their awards and briefly discuss their successes on the main stage at the Southeast Bio Investor & Partnering Forum on November 13 & 14 in Atlanta, GA. Winners will also be featured in the conference materials and website.

    Join us in celebrating those who have created lasting value for our region by nominating them - or yourself! - for this special recognition. Eligible companies are those who have achieved the category milestone since November 1, 2017 and who have headquarters or substantial operations in the Southeast US.


    The deadline for nominations is Monday, September 17 at noon ET. Please submit nominations to Evan McClure MD or by clicking here. For additional information, contact David L. Day, Executive Director of SEBIO here.


    About SEBIO
    Southeast BIO (SEBIO) is a regional non-profit organization that fosters the growth of the life sciences industry in the Southeastern United States through efforts that promote entrepreneurship and bring together the key players active in the development of the industry. SEBIO's geographic footprint includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. We focus on key industries within the life sciences, including: bio/pharma, medical devices and technology, agricultural biotechnology, animal health, bioinformatics, and biomaterials.

    Continue to the original article

  • 15 Aug 2018 9:32 AM | Anonymous member (Administrator)


    The Bio Brouhaha is back, and better than ever. Again we will meet other members of Birmingham's life sciences community over refreshments in an informal setting. On August 23, from 5:30-7:30 PM, as part of the Brouhaha "THESE ARE THE PEOPLE IN YOUR NEIGHBORHOOD" series, we will convene at Innovation Depot, home to numerous highly dynamic life science startups. 

    They include companies offering medical diagnostics, fermented foods, cell lines, medical devices, regenerative medicine, and proteomics (just to name a few). Many thanks to Innovation Depot, Bradley Arant, and BIO Alabama for their support!  We look forward to seeing you there.

  • 14 Aug 2018 9:16 AM | Anonymous member (Administrator)

    DEADLINE EXTENDED - LAST OPPORTUNITY!

    Introduce your company to targeted investors, VCs, and potential partners at the 2018 Southeast BIO Investor & Partnering Forum.

    The Forum provides opportunities for both early and mid- to late-stage companies that are looking for investment and business partners. Learn more about applying.

    The deadline for completed applications is 
    Tuesday, August 28, 2018.

    As a presenter you'll gain:

    • Visibility among potential investors and industry partners
    • A private advisory session with experienced business professional for early-stage companies
    • The opportunity to present to an audience of 350+ attendees
    • Complimentary registration for company representatives
    • Access to SEBIO Connect for scheduling one-on-one meetings
    • Inclusion in conference materials before, during, and after the event
    • Inclusion in the conference mobile app and website
    • Media exposure

    Start your application today!  Don't have time to complete it now?  Log in anytime
    up until the deadline to finish it.


    The application deadline has been extended through Tuesday, August 28, 2018.

    Venture funds that regularly attend SEBIO include:

    GRA 
    Venture Fund | Harbert Venture Partners | Hatteras Venture Partners | HealthQuest Ventures | H.I.G. Capital | J&J Development Corporation | Lilly Ventures | Lumira Capital | Merck | MPM Capital | New Enterprise Associates | Osage University Partners | Pappas Capital | Pappas Ventures | Southeast Investor Group | SR One | and many more!

    Bookmark the conference webpage to stay up-to-date on the Forum including announcements on the program, details on exclusive networking, and to ensure 
    your spot by registering now.


    Read The Original Article Here


  • 11 Jun 2018 7:33 AM | Anonymous member (Administrator)

    Over the final two decades of the 20th century and into the 21st, Alabama’s biotechnology sector developed steadily. It rose from the foundation established by the emergence of Birmingham — particularly the University of Alabama at Birmingham and the nonprofit Southern Research — as a leading national center for medical and scientific research.

    By the mid-1980s, UAB and local business leaders were moving to facilitate the commercialization of research and actively support the business climate for startups in biotech and other technology-related fields. That led to the creation in 1986 of the Office for the Advancement of Developing Industries (OADI).

    As an “incubator” for tech-based industries, OADI was successful from the beginning. In 2006, it was merged with small-business incubator The Entrepreneurial Center, and the following year — renamed Innovation Depot — moved into a renovated former Sears flagship in downtown Birmingham, where it has become one of the nation’s leading startup programs. Since 2010 alone, Innovation Depot has housed well over 100 companies, accounting for a combined economic impact of nearly $1.5 billion.

    Meanwhile, other biotech ventures across Alabama were finding success in their own right. Among the highlights:

    BioCryst Pharmaceuticals. Founded in 1986, BioCryst began as a tenant at OADI, developing antiviral drugs. The company went public in 1994, and by 2008 was recognized as one of the fastest-growing tech-based companies in America.

    Brookwood Pharmaceuticals. A spinoff of Southern Research — co-founder Art Tipton would become CEO of Southern Research in 2013 — Brookwood built its business on supplying biodegradable polymers. The company was acquired by Minnesota-based SurModics in 2007.

    HudsonAlpha Institute for Biotechnology. Opened in Huntsville in 2008, the nonprofit HudsonAlpha engages scientists, educators, clinicians and entrepreneurs in collaborating to apply genomic sciences to improving human health and well-being around the world.

    Evonik. In 2014, the German-based Evonik — one of the world’s leading specialty chemical companies — chose Birmingham as the site of its first global “Innovation Center.” In an interesting twist on Alabama’s biotech history, the company in 2011 had acquired SurModics, the firm that bought Birmingham’s Brookwood Pharmaceuticals four years earlier. In March 2018, Evonik capped off $50 million in investments over its four years in Birmingham by making its Birmingham facility the site of its global Competence Center for Medical Devices.

    Baxter. A Fortune 500 healthcare company based in Illinois, Baxter acquired Swedish-based medical equipment maker Gambro in 2012. Two years later, Baxter announced a $300 million investment in expansion of the existing Gambro facility in Opelika, adding 200 jobs to the southeast Alabama community.

    Oxford Pharmaceuticals. In 2016, British-based Oxford opened a new $29 million, 200-employee manufacturing and distribution facility in Jefferson County.

    In part, the ongoing — and, of late, accelerating — evolution of Alabama’s biotech sector is an outgrowth of the change in the state’s economic development strategy that also began in the mid-1980s. Especially as it related to biotech and life sciences, a more collaborative and forward-looking approach took hold. Today, the results of that are becoming apparent.

    “By working together across the state,” says Carter Wells, vice president for economic development at HudsonAlpha, “Alabama continues to grow as the biotech hub of the Southeast. Our company is proud to play a significant role in the state’s success.”

    Even so, obstacles remain for Alabama to achieve its full potential in biotech. One is access to capital, not only to fuel the startup culture, but also to encourage companies founded in Alabama to remain in the state. Another is being intentional about workforce development, ensuring the availability of education, training, jobs and entrepreneurial opportunities necessary to develop a true “ecosystem” for the kind of growth that gave rise to tech hubs like Silicon Valley.

    Part of that comes from the presence of an entity like HudsonAlpha. As Wells notes, the institute’s “unique model” enables it not only to attract biosciences companies, but also to “train the next generation of scientists and grow Alabama’s biotech workforce.”

    Another part of that effort is Bronze Valley. Launched in 2018, the Birmingham-based nonprofit is focused on workforce development and access to capital, as well as commercialization of science- and technology-based discoveries made at established research centers around Alabama. Most particularly, the organization is working to create an education-to-opportunity pipeline for ethnic minorities and women, who currently are underrepresented in technology careers, as entrepreneurs and in other fields where innovators will lead the way in creating the jobs of the future.

    “It’s about creating and perpetuating a culture of innovation,” says John O. Hudson III, chairman of the board for Bronze Valley and senior vice president for marketing and business development for Alabama Power. “We have the momentum and the ingredients, and now we’re putting the collaborative infrastructure in place to support transformational growth.”

    This is the last in a series of three articles on the history of biotech in Alabama. Mark Kelly is a Birmingham writer who is a senior market specialist for Alabama Power.

    Read The Original Article Here

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
Post Office Box 13906
Birmingham, AL 35202

administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software